Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
6.78
+0.10 (1.50%)
At close: Jan 8, 2026, 4:00 PM EST
6.77
-0.01 (-0.15%)
Pre-market: Jan 9, 2026, 7:07 AM EST
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $73.88 million as of January 9, 2026. Its market cap has increased by 631.46% in one year.
Market Cap
73.88M
Enterprise Value
71.29M
1-Year Change
631.46%
Ranking
Category
Stock Price
$6.78
Market Cap Chart
Since January 25, 1999, Kazia Therapeutics's market cap has decreased from $2.78B to $73.88M, a decrease of -97.34%. That is a compound annual growth rate of -12.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 54.10M | -3.05% |
| Dec 31, 2025 | 55.80M | 845.76% |
| Dec 31, 2024 | 5.90M | -41.00% |
| Dec 29, 2023 | 10.00M | 17.65% |
| Dec 30, 2022 | 8.50M | -92.36% |
| Dec 31, 2021 | 111.20M | 36.11% |
| Dec 31, 2020 | 81.70M | 202.59% |
| Dec 31, 2019 | 27.00M | 128.81% |
| Dec 31, 2018 | 11.80M | -23.38% |
| Dec 29, 2017 | 15.40M | -38.89% |
| Dec 30, 2016 | 25.20M | -28.81% |
| Dec 31, 2015 | 35.40M | 152.86% |
| Dec 31, 2014 | 14.00M | -41.18% |
| Dec 31, 2013 | 23.80M | -16.20% |
| Dec 31, 2012 | 28.40M | 246.34% |
| Dec 30, 2011 | 8.20M | -21.15% |
| Dec 31, 2010 | 10.40M | -79.28% |
| Dec 31, 2009 | 50.20M | 3.29% |
| Dec 31, 2008 | 48.60M | -54.66% |
| Dec 31, 2007 | 107.20M | -45.78% |
| Dec 29, 2006 | 197.70M | -43.95% |
| Dec 30, 2005 | 352.70M | -16.46% |
| Dec 31, 2004 | 422.20M | -19.12% |
| Dec 31, 2003 | 522.00M | 186.18% |
| Dec 31, 2002 | 182.40M | -93.43% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 1.01T |
| Johnson & Johnson | 499.18B |
| AbbVie | 407.59B |
| UnitedHealth Group | 309.33B |
| AstraZeneca | 297.23B |
| Merck & Co. | 275.63B |
| Novartis AG | 273.49B |
| Novo Nordisk | 254.60B |